---
title: Swiss BioQuant AG vs Synexa Life Sciences
slug_a: swissbioquant
slug_b: synexagroup
site: cro
review_signal_gate: closed
canonical_path: /compare/swissbioquant/synexagroup
generated_by: BioBM Editorial AI
---

# Swiss BioQuant AG vs Synexa Life Sciences

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Swiss BioQuant AG (swissbioquant) is listed for cro. Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.

Services: 6. Modalities: 6. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Synexa Life Sciences (synexagroup) is listed for cro. Biomarker and bioanalytical CRO offering custom assay development, validation and clinical sample analysis by LC-MS/MS, MSD, flow cytometry and Olink proteomics. Labs in Manchester, Turku and Cape Town support work from discovery through regulatory submission.

Services: 10. Modalities: 6. Indications: 3. Locations: 3. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.